Outcome of Board meeting held on 11-02-2026 for noting of granting and vesting of options approved by NRC committee of the Company.
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Neogen Chemicals Limited held a board meeting on 11 February 2026 where the board noted the granting and vesting of employee stock options approved by the Nomination and Remuneration Committee (NRC). This is a routine disclosure under SEBI regulations requiring listed companies to inform exchanges about stock option-related decisions. No specific number of options or grant price has been detailed in the headline, though such details would typically appear in the detailed filing. The move reflects the company's ongoing employee incentive and retention strategy through its ESOP scheme.
Generally a neutral to mildly positive signal as ESOP grants align employee interests with shareholders. The absence of any specific numbers in the headline limits immediate price impact, but investors should review the detailed filing for grant size and dilution impact.